mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-05 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |